Robert J. Rounbehler

1.5k total citations
18 papers, 737 citations indexed

About

Robert J. Rounbehler is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Robert J. Rounbehler has authored 18 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Robert J. Rounbehler's work include Prostate Cancer Treatment and Research (7 papers), Cancer-related Molecular Pathways (6 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Robert J. Rounbehler is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Cancer-related Molecular Pathways (6 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Robert J. Rounbehler collaborates with scholars based in United States, Canada and Australia. Robert J. Rounbehler's co-authors include D. Gale Johnson, Claudio J. Conti, John L. Cleveland, Mohammad Fallahi, John T. Powers, Chunying Yang, Raju V. Pusapati, Mark J. McArthur, Pamela M. Rogers and Mingshan Yan and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and PLoS ONE.

In The Last Decade

Robert J. Rounbehler

17 papers receiving 734 citations

Peers

Robert J. Rounbehler
Meaghan A. Delaney United States
Nikolina Vlatković United Kingdom
Shuet Theng Lee Singapore
Hiu‐Fung Yuen Hong Kong
Elsie White United States
Shahryar E. Mir Netherlands
Julia Bárdos United Kingdom
Robert J. Rounbehler
Citations per year, relative to Robert J. Rounbehler Robert J. Rounbehler (= 1×) peers Abdelkader Selmi

Countries citing papers authored by Robert J. Rounbehler

Since Specialization
Citations

This map shows the geographic impact of Robert J. Rounbehler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Rounbehler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Rounbehler more than expected).

Fields of papers citing papers by Robert J. Rounbehler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Rounbehler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Rounbehler. The network helps show where Robert J. Rounbehler may publish in the future.

Co-authorship network of co-authors of Robert J. Rounbehler

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Rounbehler. A scholar is included among the top collaborators of Robert J. Rounbehler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Rounbehler. Robert J. Rounbehler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ratan, Aakrosh, Michelle L. Churchman, Laura Graham, et al.. (2025). Clinical and Genomic Features of Androgen Indifferent Prostate Cancer. International Journal of Molecular Sciences. 26(2). 679–679. 1 indexed citations
2.
Awasthi, Shivanshu, Anders Berglund, Robert J. Rounbehler, et al.. (2020). Comparative Genomics to Uncover Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 108(3). S120–S121.
3.
Yamoah, Kosj, Priti Lal, Shivanshu Awasthi, et al.. (2020). TMPRSS2‐ERG fusion impacts anterior tumor location in men with prostate cancer. The Prostate. 81(2). 109–117. 9 indexed citations
4.
Berglund, Anders, Robert J. Rounbehler, Shivanshu Awasthi, et al.. (2019). Commercial Gene Expression Tests for Prostate Cancer Prognosis Provide Paradoxical Estimates of Race-Specific Risk. Cancer Epidemiology Biomarkers & Prevention. 29(1). 246–253. 17 indexed citations
5.
Echevarria, Michelle, Shivanshu Awasthi, Chia‐Ho Cheng, et al.. (2019). African American Specific Gene Panel Predictive of Poor Prostate Cancer Outcome. The Journal of Urology. 202(2). 247–255. 21 indexed citations
6.
Rounbehler, Robert J., Anders Berglund, Travis Gerke, et al.. (2018). Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate Cancer. Cancer Epidemiology Biomarkers & Prevention. 27(11). 1376–1383. 7 indexed citations
7.
Berglund, Anders, Robert J. Rounbehler, Travis Gerke, et al.. (2018). Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer. Prostate Cancer and Prostatic Diseases. 22(2). 292–302. 10 indexed citations
8.
Luu, Hung N., Hui‐Yi Lin, Karina D. Sørensen, et al.. (2017). miRNAs associated with prostate cancer risk and progression. BMC Urology. 17(1). 18–18. 91 indexed citations
9.
Berglund, Anders, Kristen E.N. Scott, Weimin Li, et al.. (2016). Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function. Oncotarget. 7(50). 83462–83475. 6 indexed citations
10.
Fallahi, Mohammad, Antonio L. Amelio, John L. Cleveland, & Robert J. Rounbehler. (2014). CREB Targets Define the Gene Expression Signature of Malignancies Having Reduced Levels of the Tumor Suppressor Tristetraprolin. PLoS ONE. 9(12). e115517–e115517. 26 indexed citations
11.
Rounbehler, Robert J., Mohammad Fallahi, Chunying Yang, et al.. (2012). Tristetraprolin Impairs Myc-Induced Lymphoma and Abolishes the Malignant State. Cell. 150(3). 563–574. 91 indexed citations
12.
Rounbehler, Robert J., Weimin Li, Mark A. Hall, et al.. (2009). Targeting Ornithine Decarboxylase Impairs Development of MYCN -Amplified Neuroblastoma. Cancer Research. 69(2). 547–553. 79 indexed citations
13.
Pusapati, Raju V., et al.. (2009). E2F2 suppresses Myc‐induced proliferation and tumorigenesis. Molecular Carcinogenesis. 49(2). 152–156. 37 indexed citations
14.
Pusapati, Raju V., Robert J. Rounbehler, John T. Powers, et al.. (2006). ATM promotes apoptosis and suppresses tumorigenesis in response to Myc. Proceedings of the National Academy of Sciences. 103(5). 1446–1451. 122 indexed citations
15.
Marval, Paula L. Miliani de, Everardo Macías, Robert J. Rounbehler, et al.. (2004). Lack of Cyclin-Dependent Kinase 4 Inhibits c- myc Tumorigenic Activities in Epithelial Tissues. Molecular and Cellular Biology. 24(17). 7538–7547. 85 indexed citations
16.
Rounbehler, Robert J., Pamela M. Rogers, Claudio J. Conti, & D. Gale Johnson. (2002). Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.. PubMed. 62(11). 3276–81. 38 indexed citations
17.
Russell, Jamie L., John T. Powers, Robert J. Rounbehler, et al.. (2002). ARF Differentially Modulates Apoptosis Induced by E2F1 and Myc. Molecular and Cellular Biology. 22(5). 1360–1368. 62 indexed citations
18.
Rounbehler, Robert J., Robin Schneider‐Broussard, Claudio J. Conti, & D. Gale Johnson. (2001). Myc lacks E2F1's ability to suppress skin carcinogenesis. Oncogene. 20(38). 5341–5349. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026